Evidence map›Paper›PMID 20304832›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2010

Translation control: a multifaceted regulator of inflammatory response.

Barsanjit Mazumder, Xiaoxia Li, Sailen Barik

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular dynamics of inflammation resolution: therapeutic implications.Frontiers in cell and developmental biology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Theranostics · 2023
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Barsanjit MazumderDepartment of Biology, Geology and Environmental Science, Center for Gene Regulation in Health and Disease, College of Science, Cleveland State University, Cleveland, OH 44115, USA. b.mazumder@csuohio.edu
Xiaoxia Li
Sailen Barik
Cleveland Clinic · USCleveland State University · USUniversity of South Alabama · US

Funding

Translational Silencing in Monocytes: Role of L13aR01HL079164 · NHLBI · CLEVELAND STATE UNIVERSITY · PI MAZUMDER, BARSANJIT · 2005 to 2019
$4.5M
SIGIRR A Negative Regulator of Toll-IL-IR SignalingR01AI060632 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, XIAOXIA · 2005 to 2009
$1.8M
Mechanisms of RNA virus-host interactionR01AI059267 · NIAID · UNIVERSITY OF SOUTH ALABAMA · PI BARIK, SAILEN · 2005 to 2009
$1.2M
NHLBI NIH HHS R01 HL079164NHLBI NIH HHS R01HL79164NIAID NIH HHS R01 AI059267NIAID NIH HHS R01AI059267NIAID NIH HHS R01 AI060632NIAID NIH HHS R01AI060632
6 · The paper itself

Abstract

A robust innate immune response is essential to the protection of all vertebrates from infection, but it often comes with the price tag of acute inflammation. If unchecked, a runaway inflammatory response can cause significant tissue damage, resulting in myriad disorders, such as dermatitis, toxic shock, cardiovascular disease, acute pelvic and arthritic inflammatory diseases, and various infections. To prevent such pathologies, cells have evolved mechanisms to rapidly and specifically shut off these beneficial inflammatory activities before they become detrimental. Our review of recent literature, including our own work, reveals that the most dominant and common mechanism is translational silencing, in which specific regulatory proteins or complexes are recruited to cis-acting RNA structures in the untranslated regions of single or multiple mRNAs that code for the inflammatory protein(s). Enhancement of the silencing function may constitute a novel pharmacological approach to prevent immunity-related inflammation.

Indexed as

AnimalsGene ExpressionGene Expression RegulationHumansInflammationProtein Biosynthesis

Identifiers

PMID20304832
PMCPMC2860598
OpenAlexW2130733957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.